The U.S. FDA approved Roche Holding Ltd.'s Elecsys troponin T blood test to diagnose patients with a suspected heart attack.
This makes Roche the first in-vitro diagnostics company in the U.S. to provide the next generation blood test.
Discover more about S&P Global’s offerings